AMPLIPHI BIOSCIENCES CORP has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in China, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are KALINSKI PAWEL, CHS PHARMA INC and BIOMUNE.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Basic materials chemistry | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Morales Sandra P | 5 |
#2 | Jia Ying | 5 |
#3 | Mearns Gillian | 4 |
#4 | Rankin Deborah A | 4 |
#5 | Smremar Frenk | 2 |
#6 | Smrekar Frenk | 1 |
#7 | Harper David | 1 |
#8 | Bilinsky Igor P | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019136108A1 | Bacteriophage compositions for treating pseudomonas infections | |
CN112218659A | Therapeutic phage compositions for the treatment of staphylococcal infections |